Semaglutide for Cardiovascular Health in Obesity
In a cutting-edge study, Semaglutide, renowned for its role in diabetes and weight management, emerges as a potential game-changer in combating CVD among individuals battling obesity. Despite some side effects, the prospect of a remarkable 20% reduction in cardiovascular risk in this high-risk group sparks undeniable excitement.